Insider holders · CIK 0001140098
Ocata Therapeutics, Inc. · OCAT
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Eddy AngladeChief Medical Officer | 0 | — | 0 | Feb 11, 2016 · 4:30 pm EST | Form 4 |
| Michael Thomas HeffernanDirector | 0 | — | 0 | Feb 11, 2016 · 4:29 pm EST | Form 4 |
| Edward H MylesCOO & CFO | 0 | — | 0 | Feb 11, 2016 · 4:35 pm EST | Form 4 |
| Robert LanzaChief Scientific Officer | 0 | — | 0 | Feb 11, 2016 · 4:36 pm EST | Form 4 |
| H Le Roux JoosteSVP of Bus Development & CCO | 0 | — | 0 | Feb 11, 2016 · 4:33 pm EST | Form 4 |
| Paul K WottonPresident and CEO | 0 | — | 0 | Feb 11, 2016 · 4:26 pm EST | Form 4 |
| Zohar LoshitzerDirector | 0 | — | 0 | Feb 11, 2016 · 4:28 pm EST | Form 4 |
| Brian LevyDirector | 0 | — | 0 | Feb 11, 2016 · 4:33 pm EST | Form 4 |
| Robert LangerDirector | 0 | — | 0 | Feb 11, 2016 · 4:27 pm EST | Form 4 |
| Gregory D PerryDirector | 0 | — | 0 | Feb 11, 2016 · 4:34 pm EST | Form 4 |
| Alan C ShapiroDirector | — | 0 | 0 | Feb 11, 2016 · 4:32 pm EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.